Two additional cardiac hypertrophy models: a genetically modified mouse model overexpressing the activating transcription factor 3 (ATF3) in cardiomyocytes [19], and a phenylephrine (PE) infusion representing a hypertension mouse model [20], were used to study tumor growth in our lab. This evidence concerns the gene ATF3 and cardiac hypertrophy.